Rankings
▼
Calendar
OCGN
Ocugen, Inc.
$710M
Q4 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$8M
Net Income
-$8M
EPS (Diluted)
$-37.76
Balance Sheet
Total Assets
$37M
Total Liabilities
$9M
Stockholders' Equity
$28M
Cash & Equivalents
$31M
← FY 2015
All Quarters
Q1 2016 →
OCGN Q4 2015 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena
